股票代码：001316 股票简称：润贝航科 公告编号：2025-036 润贝航空科技股份有限公司 第二届董事会第十九次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 润贝航空科技股份有限公司（以下简称"公司"）第二届董事会第十九次会议 的会议通知于 2025 年 7 月 16 日以电子邮件形式送达至全体董事，会议于 2025 年 7 月 18 日上午 10:00 在公司会议室以现场结合通讯方式召开。本次会议由董 事长刘俊锋先生召集并主持，公司现有董事 7 名，实际出席会议并表决的董事 高级管理人员列席了本次会议。会议的召集、召开、表决程序符合《中华人民共 和国公司法》及《润贝航空科技股份有限公司章程》的有关规定，本次会议的召 开合法有效。经与会董事审议，形成决议如下： 二、董事会会议审议情况 经与会董事审议，形成决议如下： （一）审议通过《关于 2023 年限制性股票激励计划预留授予部分第一个解 除限售期解除限售条件成就的议案》 公司董事会对公司 2023 年限制性股票激励计划预留授予部分第一个解除限 售期的解除限售条件进 ...

无锡德林海环保科技股份有限公司（以下简称"公司"）第三届董事会第二 十六次会议于 2025 年 7 月 18 日以现场结合通讯方式召开，会议通知于 2025 年 名，实际参会董事 7 名。会议的召集、召开和表决情况符合《中华人民共和国公 司法》（以下简称"《公司法》"）等有关法律、法规及《无锡德林海环保科技 股份有限公司章程》（以下简称"《公司章程》"）的规定，形成的决议合法、 有效。 二、董事会会议审议情况 经与会董事投票表决，审议通过了如下议案： 证券代码：688069 证券简称：德林海 公告编号：2025-027 无锡德林海环保科技股份有限公司 第三届董事会第二十六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 （一）审议并通过《关于公司董事会换届选举暨提名第四届董事会非独立 董事候选人的议案》 鉴于公司第三届董事会任期将届满，根据《公司法》《上海证券交易所科创 板上市公司自律监管指引第 1 号——规范运作》等法律法规、规范性文件及《公 司章程》的有关规定，公司按照相关法律程序 ...

北京市中伦律师事务所 关于北京神州泰岳软件股份有限公司 暨第二个归属期归属条件成就的 法律意见书 二〇二五年七月 法律意见书 北京市中伦律师事务所 关于北京神州泰岳软件股份有限公司 第二个归属期归属条件成就的 法律意见书 致：北京神州泰岳软件股份有限公司 北京市中伦律师事务所（以下简称"本所"）接受北京神州泰岳软件股份有 限公司（简称"公司"或"神州泰岳"）的委托，就公司 2023 年限制性股票激励 计划（以下简称"激励计划"或"本次激励计划"）的相关事宜担任专项法律顾 问，就本次激励计划授予价格调整（以下简称"本次调整"）、第二个归属期归属 条件成就事项（以下简称"本次归属"）出具本法律意见书。 为出具本法律意见书，本所律师审阅了《北京神州泰岳软件股份有限公司 《北京神州泰岳软件股份有限公司 2023 年 限制性股票激励计划实施考核管理办法》 《北京神州泰岳软件股份有限公司 2023 年限制性股票激励计划激励对象名单》、公司相关会议文件、独立董事的独立意 见、公司的书面说明以及本所律师认为需要审查的其他文件，并通过查询政府部 门公开信息、公司披露的公开信息对相关的事实和资料进行了核查和验证。 法律意见书 声 ...

证券代码：301393 证券简称：昊帆生物 公告编号：2025-040 七次会议，审议通过了《关于向激励对象授予预留部分限制性股票的议案》《关 于调整 2024 年限制性股票激励计划授予价格的议案》。公司董事会薪酬与考核 委员会已审议并通过上述议案，并对激励对象名单进行核实并发表了核查意见。 会第九次会议，审议通过了《关于 2024 年限制性股票激励计划首次授予部分第 一个归属期符合归属条件的议案》《关于作废部分已授予尚未归属的限制性股票 的议案》。公司董事会薪酬与考核委员会已审议并通过上述议案，并对首次授予 部分第一个归属期归属名单进行核实并发表了核查意见。 二、本次作废处理限制性股票的原因和数量 苏州昊帆生物股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 苏州昊帆生物股份有限公司（以下简称"公司"或"昊帆生物"）于 2025 年 7 月 18 日召开第四届董事会第十一次会议和第四届监事会第九次会议，审议 通过了《关于作废部分已授予尚未归属的限制性股票的议案》。现将有关事项说 明如下： 一、公司 2024 年限制性股票激励计划已履行的决策程序和 ...

首次授予部分第一个归属期归属名单的核查意见 董事会薪酬与考核委员会关于 2024 年限制性股票激励计划 苏州昊帆生物股份有限公司 （1）最近 12 个月内被证券交易所认定为不适当人选； 苏州昊帆生物股份有限公司（以下简称"公司"）董事会薪酬与考核委员会 依据《中华人民共和国公司法》 （以下简称"《公司法》"）、 《中华人民共和国证券 法》 （以下简称"《证券法》"）、 《上市公司股权激励管理办法》 （以下简称"《管理 办法》"）等有关法律、法规及规范性文件和《苏州昊帆生物股份有限公司章程》 （以下简称"《公司章程》"）的规定，对 2024 年限制性股票激励计划（以下简称 "本激励计划"）首次授予部分第一个归属期归属名单进行了核查，发表核查意见 如下： 激励对象不存在下列情形： 综上，董事会薪酬与考核委员会同意本次符合条件的 122 名激励对象办理归 属，对应第二类限制性股票的归属数量为 21 万股。上述事项符合相关法律、法 规及规范性文件所规定的条件，不存在损害公司及股东利益的情形。 苏州昊帆生物股份有限公司 董事会薪酬与考核委员会 （2）最近 12 个月内被中国证券监督管理委员会（以下简称"中国证监会"） ...

证券代码：301393 证券简称：昊帆生物 公告编号：2025-038 苏州昊帆生物股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 表决结果：3 名赞成，占全体监事人数的 100%；0 名弃权，0 名反对。 二、监事会会议审议情况 与会监事以记名投票表决方式，审议并通过了如下议案： （一）审议并通过《关于公司 2024 年限制性股票激励计划首次授予部分第 一个归属期符合归属条件的议案》 经审议，监事会认为： 公司 2024 年限制性股票激励计划首次授予部分第一个归属期的归属条件已 成就，本次可归属限制性股票的 122 名激励对象具备《公司法》《证券法》等法 律法规和规范性文件以及《公司章程》规定的任职资格，符合《上市公司股权激 励管理办法》 （以下简称"《管理办法》"）规定的激励对象条件，符合公司《2024 年限制性股票激励计划（草案）》 （以下简称"《激励计划（草案）》"）规定的激励 对象范围，其作为公司本次激励计划激励对象的主体资格合法、有效。 公司 2024 年限制性股票激励计划第一个归属期的归属条件已经成就，本次 ...

Core Viewpoint - The company has announced the decision to cancel a portion of the restricted stock incentive plan due to unmet performance targets, while also confirming the achievement of conditions for another portion of the stock to be vested [1][43][47]. Group 1: Board Meeting Decisions - The fourth board meeting was held on July 17, 2025, with all nine directors present, and the meeting complied with legal and regulatory requirements [1][12]. - The board approved the cancellation of 23,917 shares of restricted stock that were granted but not vested, as the company did not fully meet the performance targets [1][47]. - The board also approved the vesting of 200,083 shares of restricted stock for five eligible recipients, as the performance conditions for the first vesting period were met [6][17]. Group 2: Supervisory Board Decisions - The supervisory board held its seventh meeting on July 17, 2025, with all three supervisors present, and the meeting adhered to legal and regulatory standards [12][11]. - The supervisory board agreed with the board's decision to cancel the unvested restricted stock, confirming that it aligns with relevant regulations and does not harm shareholder interests [12][49]. - The supervisory board also approved the vesting of 200,083 shares for eligible recipients, affirming that the conditions for vesting were satisfied [14][35]. Group 3: Stock Incentive Plan Details - The stock incentive plan was initially approved on April 25, 2024, with a total of 4.18% of the company's shares allocated for the plan [18][21]. - The plan allows for the vesting of restricted stock based on performance conditions, with the first vesting period set to begin on July 18, 2025 [32][41]. - The company will source the vested shares from either repurchases in the secondary market or through directed issuance to the incentive recipients [18][36].

Core Viewpoint - The company has adjusted the stock grant price for its 2025 restricted stock incentive plan from 9.91 yuan to 9.87 yuan due to the implementation of the 2024 annual profit distribution plan, which will not materially affect the company's financial status or operational results [9][21][15]. Group 1: Meeting Details - The second meeting of the board of supervisors was held on July 17, 2025, with all three supervisors present, confirming the legality and validity of the meeting [2][4]. - The second meeting of the board of directors was also held on July 17, 2025, with all seven directors present, ensuring compliance with relevant laws and regulations [20][22]. Group 2: Stock Grant Price Adjustment - The adjustment of the stock grant price was approved unanimously by the board of supervisors and the board of directors, confirming that the adjustment process was legal and did not harm the interests of the company or its shareholders [3][21][16]. - The adjusted stock grant price of 9.87 yuan per share was determined based on the cash dividend distribution of 0.0415 yuan per share from the 2024 annual profit distribution [14][15]. Group 3: Restricted Stock Grant - The company will grant 1.08 million shares of the second category of restricted stock to 15 eligible incentive objects, with the grant date set for July 17, 2025, at a price of 9.87 yuan per share [5][23][28]. - The total number of shares granted represents 1.29% of the company's total share capital of 83.7734 million shares [28][37]. Group 4: Compliance and Legal Opinions - The company has followed all necessary procedures for the stock incentive plan, including internal announcements and approvals from the board and supervisory board [11][12][30]. - Legal opinions confirm that the adjustments and grants comply with relevant laws and regulations, and necessary approvals have been obtained [17][45].

Core Viewpoint - The legal opinion letter from Shanghai Junlan Law Firm confirms that Shenzhen Luwei Optoelectronics Co., Ltd. has made necessary adjustments to its 2024 restricted stock incentive plan, including the grant price and reserved grants, in compliance with relevant regulations [1][10]. Group 1: Approval and Authorization - The adjustments and grants have received necessary approvals from the board of directors and the supervisory board, as well as authorization from the shareholders' meeting [5][9]. - The company has complied with the "Management Measures for Equity Incentives of Listed Companies" and other relevant regulations [9][10]. Group 2: Adjustment Details - The adjusted grant price for the restricted stock is set at 17.89 yuan per share, following a calculation that accounts for a cash dividend distribution of 0.30 yuan per share [6][7]. - The total number of restricted stocks to be granted is 235,400 shares to seven eligible incentive objects [7][8]. Group 3: Disclosure Obligations - The company is required to disclose relevant documents, including the resolutions of the board and supervisory board meetings, as well as announcements regarding the adjustments to the incentive plan [9][10]. - The company has fulfilled its current information disclosure obligations and will continue to comply with future requirements [10].

Core Viewpoint - Shenzhen Suoling Industrial Co., Ltd. plans to repurchase and cancel 400,000 restricted stocks at a price of 2.60 RMB per share due to the departure of one incentive object under the 2023 incentive plan [10][12]. Group 1: Repurchase and Cancellation Details - The repurchase involves 400,000 restricted stocks that have been granted but not yet released from the lock-up period [10]. - The repurchase price is set at 2.60 RMB per share, which aligns with the granting price specified in the incentive plan [10]. - The decision to repurchase has been approved by the company's board and supervisory committee [10][12]. Group 2: Legal Compliance and Opinions - The legal opinion confirms that the repurchase and cancellation comply with relevant laws, including the Company Law and Securities Law [10][12]. - The law firm has conducted thorough verification of the facts and documents related to the incentive plan and has concluded that the repurchase is legitimate and authorized [2][10]. - The company is required to continue fulfilling its information disclosure obligations as the incentive plan progresses [12].